Published in Heart Rhythm on December 31, 2008
Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology. Cardiovasc Res (2011) 1.65
Cardiac adrenergic control and atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol (2009) 1.21
Pro-arrhythmogenic effects of atrial fibrillation-induced electrical remodelling: insights from the three-dimensional virtual human atria. J Physiol (2013) 1.18
Selective molecular potassium channel blockade prevents atrial fibrillation. Circulation (2010) 1.11
Chronic heart failure and the substrate for atrial fibrillation. Cardiovasc Res (2009) 1.05
Calcium-activated potassium current modulates ventricular repolarization in chronic heart failure. PLoS One (2014) 1.03
Mechanisms of termination and prevention of atrial fibrillation by drug therapy. Pharmacol Ther (2011) 0.94
Transient outward K+ current reduction prolongs action potentials and promotes afterdepolarisations: a dynamic-clamp study in human and rabbit cardiac atrial myocytes. J Physiol (2012) 0.89
Substrate for development of atrial fibrillation in patients with congestive heart failure: are we close to the answer? Heart Rhythm (2009) 0.80
Chronic myocardial infarction promotes atrial action potential alternans, afterdepolarizations, and fibrillation. Cardiovasc Res (2013) 0.80
Duration of heart failure and the risk of atrial fibrillation: different mechanisms at different times? Cardiovasc Res (2009) 0.79
Differential effects of the peroxynitrite donor, SIN-1, on atrial and ventricular myocyte electrophysiology. J Cardiovasc Pharmacol (2013) 0.79
Effectiveness of aldosterone antagonists for preventing atrial fibrillation after cardiac surgery in patients with systolic heart failure: a retrospective study. Clin Res Cardiol (2014) 0.77
Mechanisms of postcardiac surgery atrial fibrillation: more pieces in a difficult puzzle. Heart Rhythm (2009) 0.77
Atrial Electrophysiological Remodeling and Fibrillation in Heart Failure. Clin Med Insights Cardiol (2016) 0.75
Rhythm control strategies and the role of antiarrhythmic drugs in the management of atrial fibrillation: focus on clinical outcomes. J Gen Intern Med (2010) 0.75
SR calcium handling dysfunction, stress-response signaling pathways, and atrial fibrillation. Front Physiol (2015) 0.75
Atrial Fibrillation in Heart Failure: a Therapeutic Challenge of Our Times. Korean Circ J (2017) 0.75
Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation (1995) 8.62
Ionic mechanisms of propagation in cardiac tissue. Roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling. Circ Res (1997) 4.86
Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation (1999) 4.24
Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol (2008) 3.26
Role of the calcium-independent transient outward current I(to1) in shaping action potential morphology and duration. Circ Res (2000) 2.75
Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol (2002) 2.50
Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll Cardiol (2005) 2.43
The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation. Cardiovasc Res (2001) 2.41
Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circ Arrhythm Electrophysiol (2008) 2.37
Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation (2001) 2.27
Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation (2003) 2.16
Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res (1988) 2.13
Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation (2000) 1.83
Characterization of sustained atrial tachycardia in dogs with rapid ventricular pacing-induced heart failure. J Cardiovasc Electrophysiol (2003) 1.78
Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling. Cardiovasc Res (2003) 1.78
Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation. Circulation (2004) 1.77
Post-operative atrial fibrillation is influenced by beta-blocker therapy but not by pre-operative atrial cellular electrophysiology. J Cardiovasc Electrophysiol (2006) 1.65
Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure. Circulation (2004) 1.64
Downregulation of the calcium current in human right atrial myocytes from patients in sinus rhythm but with a high risk of atrial fibrillation. Eur Heart J (2008) 1.55
Electrophysiological and arrhythmogenic effects of 5-hydroxytryptamine on human atrial cells are reduced in atrial fibrillation. J Mol Cell Cardiol (2006) 1.53
Role of up-regulation of IK1 in action potential shortening associated with atrial fibrillation in humans. Cardiovasc Res (2005) 1.36
Cellular bases for human atrial fibrillation. Heart Rhythm (2008) 1.25
Atrial ionic remodeling induced by atrial tachycardia in the presence of congestive heart failure. Circulation (2004) 1.09
Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone. Circulation (2003) 1.06
Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. Cardiovasc Res (1999) 1.06
Contrasting efficacy of dofetilide in differing experimental models of atrial fibrillation. Circulation (2000) 1.03
Anti-adrenergic effects of endothelin on human atrial action potentials are potentially anti-arrhythmic. J Mol Cell Cardiol (2006) 1.03
Alterations in muscarinic K+ channel response to acetylcholine and to G protein-mediated activation in atrial myocytes isolated from failing human hearts. Circulation (1994) 1.02
Calcium currents in diseased human cardiac cells. J Cardiovasc Pharmacol (1995) 0.97
Management of atrial fibrillation in patients with heart failure. Eur Heart J (2007) 0.93
Depressed transient outward and calcium currents in dilated human atria. Cardiovasc Res (1994) 0.92
Altered transient outward current in human atrial myocytes of patients with reduced left ventricular function. J Cardiovasc Electrophysiol (2000) 0.88
Comparison of calcium-current in isolated atrial myocytes from failing and nonfailing human hearts. Mol Cell Biochem (1996) 0.85
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet (2002) 17.19
C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes (2002) 3.59
Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet (2009) 2.28
A randomized trial comparing treatments for varicose veins. N Engl J Med (2014) 2.20
The short QT syndrome: proposed diagnostic criteria. J Am Coll Cardiol (2011) 1.99
Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension (2004) 1.92
Mortality in adults with newly diagnosed and chronic epilepsy: a retrospective comparative study. Lancet Neurol (2006) 1.83
Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling. Cardiovasc Res (2003) 1.78
Observation or operation for patients with an asymptomatic inguinal hernia: a randomized clinical trial. Ann Surg (2006) 1.73
Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial. Invest Ophthalmol Vis Sci (2011) 1.66
Predictors of pharmacoresistant epilepsy. Epilepsy Res (2007) 1.65
Post-operative atrial fibrillation is influenced by beta-blocker therapy but not by pre-operative atrial cellular electrophysiology. J Cardiovasc Electrophysiol (2006) 1.65
Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open (2011) 1.64
Characterisation of the Na, K pump current in atrial cells from patients with and without chronic atrial fibrillation. Cardiovasc Res (2003) 1.62
Electrophysiological and arrhythmogenic effects of 5-hydroxytryptamine on human atrial cells are reduced in atrial fibrillation. J Mol Cell Cardiol (2006) 1.53
The safety and adequacy of antithrombotic therapy for atrial fibrillation: a regional cohort study. Br J Gen Pract (2006) 1.47
The effectiveness of cognitive behavior therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trial. J Pers Disord (2006) 1.46
Greater response to cardiac resynchronization therapy in patients with true complete left bundle branch block: a PREDICT substudy. Europace (2011) 1.39
Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years. BMJ (2002) 1.37
Cellular bases for human atrial fibrillation. Heart Rhythm (2008) 1.25
The "PRIM" study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. Am J Obstet Gynecol (2006) 1.11
Using patient-reported outcomes in schizophrenia: the Scottish Schizophrenia Outcomes Study. Psychiatr Serv (2009) 1.10
The role of covariates in estimating treatment effects and risk in long-term clinical trials. Stat Med (2002) 1.08
A pragmatic randomised, controlled trial of intensive care follow up programmes in improving longer-term outcomes from critical illness. The PRACTICAL study. BMC Health Serv Res (2007) 1.07
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics. Curr Control Trials Cardiovasc Med (2002) 1.07
The cost-effectiveness of cognitive behavior therapy for borderline personality disorder: results from the BOSCOT trial. J Pers Disord (2006) 1.06
Targeting sphingosine-1-phosphate signalling for cardioprotection. Curr Opin Pharmacol (2008) 1.04
A randomized controlled trial of cognitive behavior therapy for borderline personality disorder: rationale for trial, method, and description of sample. J Pers Disord (2006) 1.04
Trial protocol OPPTIMUM-- does progesterone prophylaxis for the prevention of preterm labour improve outcome? BMC Pregnancy Childbirth (2012) 1.03
Anti-adrenergic effects of endothelin on human atrial action potentials are potentially anti-arrhythmic. J Mol Cell Cardiol (2006) 1.03
Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? J Am Coll Cardiol (2003) 1.02
Are there socioeconomic differences in responses to a commonly used self report measure of chronic illness? Int J Epidemiol (2005) 1.02
The use of a novel nitinol guidewire to facilitate transseptal puncture and left atrial catheterization for catheter ablation procedures. Europace (2011) 0.98
Cognitive therapy v. usual treatment for borderline personality disorder: prospective 6-year follow-up. Br J Psychiatry (2010) 0.95
Exploring change processes in compassion focused therapy in psychosis: results of a feasibility randomized controlled trial. Br J Clin Psychol (2012) 0.94
Recruitment to publicly funded trials--are surgical trials really different? Contemp Clin Trials (2008) 0.94
Electrophysiological effects of 5-hydroxytryptamine on isolated human atrial myocytes, and the influence of chronic beta-adrenoceptor blockade. Br J Pharmacol (2003) 0.92
A mobile phone intervention to reduce binge drinking among disadvantaged men: study protocol for a randomised controlled cost-effectiveness trial. Trials (2014) 0.91
Mortality in epilepsy. Epilepsy Behav (2007) 0.90
A novel dietary intervention to optimize vitamin E intake of pregnant women to 15 mg/day. J Acad Nutr Diet (2012) 0.90
Usefulness of fractional flow reserve to improve diagnostic efficiency in patients with non-ST elevation myocardial infarction. Am J Cardiol (2012) 0.90
WISECARE+: Results of a European study of a nursing intervention for the management of chemotherapy-related symptoms. Eur J Oncol Nurs (2008) 0.87
The prevalence, nature, and importance of hematologic abnormalities in heart failure. Am Heart J (2006) 0.87
IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour - clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy Childbirth (2006) 0.86
Endothelin and the ischaemic heart. Curr Vasc Pharmacol (2005) 0.85
A web-based tool for teaching pharmacy practice competency. Am J Pharm Educ (2010) 0.85
Junctional rhythm--a suitable surrogate endpoint in catheter ablation of atrioventricular nodal reentry tachycardia? Pacing Clin Electrophysiol (2005) 0.85
The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery (2010) 0.82
Remodelling of human atrial K+ currents but not ion channel expression by chronic β-blockade. Pflugers Arch (2011) 0.82
A pragmatic multi-centre randomised controlled trial of fluid loading in high-risk surgical patients undergoing major elective surgery--the FOCCUS study. Crit Care (2011) 0.82
Apex-to-base dispersion of refractoriness underlies the proarrhythmic effect of hypokalaemia/hypomagnesaemia in the rabbit heart. J Electrocardiol (2002) 0.81
A feasibility randomised controlled trial of the New Orleans intervention for infant mental health: a study protocol. ScientificWorldJournal (2013) 0.81
Adrenomedullin acts via nitric oxide and peroxynitrite to protect against myocardial ischaemia-induced arrhythmias in anaesthetized rats. Br J Pharmacol (2006) 0.81
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion. Br J Pharmacol (2010) 0.80
IP(3)R-mediated Ca(2+) release is modulated by anandamide in isolated cardiac nuclei. J Mol Cell Cardiol (2008) 0.80
Electrophysiological effects of prucalopride, a novel enterokinetic agent, on isolated atrial myocytes from patients treated with beta-adrenoceptor antagonists. J Pharmacol Exp Ther (2005) 0.80
Ximelagatran compared with warfarin for the prevention of systemic embolism and stroke. An imputed placebo analysis. Cardiovasc Drugs Ther (2005) 0.80
Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia. Pacing Clin Electrophysiol (2013) 0.80
Impact and influences on caregiver outcomes at one year post-stroke. Cerebrovasc Dis (2004) 0.79
Duration of heart failure and the risk of atrial fibrillation: different mechanisms at different times? Cardiovasc Res (2009) 0.79
Power and sample size for cost-effectiveness analysis: fFN neonatal screening. Contemp Clin Trials (2011) 0.78
Designing and implementing E-health Applications in the UK's National Health Service. J Health Commun (2005) 0.77
Sarafotoxin 6c (S6c) reduces infarct size and preserves mRNA for the ETB receptor in the ischemic/reperfused myocardium of anesthetized rats. J Cardiovasc Pharmacol (2004) 0.77
Risky single-occasion drinking and disadvantaged men: will recruitment through primary care miss hazardous drinkers? Alcohol Clin Exp Res (2013) 0.76
Study of progesterone for the prevention of preterm birth in twins (STOPPIT): findings from a trial-based cost-effectiveness analysis. Int J Technol Assess Health Care (2010) 0.76
Ventricular arrhythmias in patients with heart failure secondary to reduced ejection fraction: a current perspective. Curr Opin Cardiol (2014) 0.76
Activation of protease activated receptor-2 induces delayed cardioprotection in anesthetized mice. Cardiovasc Drugs Ther (2009) 0.76
Radiation safety and ergonomics in the electrophysiology laboratory: update on recent advances. Curr Opin Cardiol (2016) 0.76
Looking for prognostic information in the ST-T segment--is it really worth it? J Electrocardiol (2004) 0.75
Assessing catheter-associated urinary tract infection - Authors' reply. Lancet (2013) 0.75
Electrophysiological and haemodynamic effects of endothelin ETA and ETB receptors in normal and ischaemic working rabbit hearts. Br J Pharmacol (2005) 0.75
RApid Primary care Initiation of Drug treatment for Transient Ischaemic Attack (RAPID-TIA): study protocol for a pilot randomised controlled trial. Trials (2013) 0.75
Stenting for atrioesophageal fistula--reply to letter from Elitzur et al. Can J Cardiol (2014) 0.75